Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report
Emerging standouts set to transform drug discovery and development, revolutionize cancer treatment, and capture big pharma interest highlighted in third annual report LONDON, June 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has re...
Clarivate Launches Research Horizon Navigator to Pinpoint Future Breakthrough Areas
Insights from the new InCites Benchmarking & Analytics module support strategic investment and demonstrate impact LONDON, June 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launchedResearch Horizon Navigator™, a powerful new A...
Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health (SDoH) Attributes from HealthWise Data
Strategic collaboration enhances insight into patient demographics and behaviors, enabling analytical precision in addressing population health outcomes LONDON, May 31, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a str...
Clarivate Celebrates 500 Institutions Adopting Rialto Marketplace Solution
Transforming the way libraries select, acquire and manage their collections of academic books LONDON, May 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces that 500 institutions around the world have selected theRialto™ ...
Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024
New report highlights innovations poised to drive significant clinical and market impact LONDON, May 22, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of theMedical Technologies to Watch in 2024 report. This ...
New Clarivate Report Indicates Solid Growth in 2024 Global Trademark Filing Activity
Analyzing six of the key trademark registers from around the world LONDON, May 21, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released theTrademark Filing and Litigation Trends 2024 Report, analyzing six of the key trademark r...
Clarivate Launches AI-Enhanced Solution to Accelerate Trademark Watching
Providing faster and more accurate answers to critical business questions LONDON, May 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, launched the first publicly available version of Trademark Watch Analyzer today at the 2024 Internat...
New Clarivate Report Reveals that the U.S., Germany and Mainland China have the most Non-Practicing Entity Litigation
Infringement declined globally from 2012 to 2019 LONDON, May 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released the2024 Non-Practicing Entity Global Litigation (NPE) Report to analyze NPE enforcement activities and their ...
OMRON Selects IPfolio from Clarivate
IP solution maximizes operational efficiency for leading automation company LONDON, May 9, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today thatOMRON has selected IPfolio™, an intellectual property management software from ...
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis LONDON, May 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intellig...
Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success
Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics LONDON, May 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announ...
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report
Three-part report investigates rapid pipeline growth, partnerships, clinical trials, and patient access challenges in cancer treatment LONDON, April 30, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, explores the ...
Clarivate joins United Nations SDG Publishers Compact
LONDON, April 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces it has signed theUnited Nations Sustainable Development Goals (UN SDGs) Publishers Compact. Signatories of the compact pledge to develop sustainable practice...
Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets
Acquisition supports critical client workflow and reporting needs with proprietary SaaS platform, automating regulatory report authoring and compliance across manufacturing operations, supply chain and quality management LONDON, April 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...
Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Health Intelligence Enabling Real-Time Tracking of Medical Device Markets
New solution offers comprehensive tracking and analysis of market share and size inBrazil, Colombia, Argentina, Chile, Peru and Ecuador LONDON, April 17, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released itsLatAm market ...
Clarivate Acquires AI Start Up to Accelerate Strategy and Business Development Success for Life Sciences & Healthcare Clients
Acquisition of MotionHall reinforces strategy to lead market-specific solutions, including workflows and expert services fuelled by industry vertical AI LONDON, March 21, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, has announced an agr...
Clarivate Reveals Top 100 Global Innovators 2024
New report introduces rankings for the first time; Samsung Electronics leads the list LONDON, March 5, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today revealed its 2024 list of Top 100 Global Innovators™ – organizations leading the...
Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company's Board of Directors
Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the Company's Management and Board, andannounces it now has a 10.1% shareholding in the Company and can increase its participation up to 17.5% LONDON and AMSTERDAM, March 4, 2024 /PRNewswire/ -- Clarivat...
Clarivate Recognized in the WTR 1000 2024 for Trademark Business
Highly recommended in trademark management, searching and watching, renewals and recordals LONDON, Feb. 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, has been recognized in theWTR 1000 2024 by the World Trademark Review. This guide...
Clarivate Launches New Center for Intellectual Property and Innovation Research
Bringing together expertise, operational practice knowledge and powerful data models to improve innovation and IP decision-making LONDON, Feb. 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launched the Clarivate Center for IP...
